Evidence map›Paper›PMID 24893290›Full record

Trial reportPloS one2014

Smoking cessation and the risk of diabetes mellitus and impaired fasting glucose: three-year outcomes after a quit attempt.

James H Stein, Asha Asthana, Stevens S Smith, Megan E Piper, Wei-Yin Loh, Michael C Fiore, Timothy B Baker

2 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00332644 phase4completednot on this map

Pharmacotherapies: Efficacy, Mechanisms and Algorithms

TypeinterventionalSponsorUniversity of Wisconsin, MadisonRan2004 to 2010Enrolled1,504ConditionsNicotine DependenceArmsnicotine patch, nicotine lozenge, nicotine patch + nicotine lozenge, bupropion, bupropion + lozenge
NCT03612336 nacompletednot on this mapstarted 2018, after this paper: background citation

Substudy of Efficacy, Safety and Toxicology of Electronic Nicotine Delivery Systems as an Aid for Smoking Cessation (ESTxENDS Trial)- the Metabolic Substudy of ESTxENDS

TypeinterventionalSponsorUniversity of BernRan2018 to 2023Enrolled1,246ConditionsSmoking Cessation, Cardiovascular DiseasesArmsENDS (vaporizer/e-cig) and smoking cessation counseling, Smoking cessation counseling
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Interventions for preventing weight gain after smoking cessation.The Cochrane database of systematic reviews · 2021
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

James H SteinDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.
Asha AsthanaDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.
Stevens S SmithDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.
Megan E PiperDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.
Wei-Yin LohDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.
Michael C FioreDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.
Timothy B BakerDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.

Funding

Institutional Clinical and Translational Science AwardUL1TR000427 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$32.2M
INSTITUTIONAL CTSA (UW-MADISON): CLINICAL TRIALSUL1RR025011 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2007 to 2011
$29.5M
Testing Relapse Recovery Intervention ComponentsP01CA180945 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BOLT, DANIEL M · 2014 to 2023
$23.0M
Enhancing the Effectiveness of Varenicline Based Smoking Cessation TreatmentR01HL109031 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI BAKER, TIMOTHY B, STEIN, JAMES H · 2011 to 2020
$17.5M
Transforming The Treatment of Tobacco Use in Health Care: Seizing The Potential of the Electronic Health Record to Deliver Comprehensive Chronic Care Treatment for SmokingR35CA197573 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI MICHAEL C FIORE · 2015 to 2026
$10.7M
Tobacco Dependence: Treatment and OutcomesP50DA019706 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI JACKSON, THOMAS C · 2004 to 2008
$8.6M
Training in Translational Tobacco ScienceK05CA139871 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BAKER, TIMOTHY B · 2008 to 2012
$850k
NCATS NIH HHS UL1 TR000427NCI NIH HHS K05 CA139871NCI NIH HHS K05CA139871NCI NIH HHS P01 CA180945NCRR NIH HHS UL1 RR025011NCRR NIH HHS UL1RR025011NHLBI NIH HHS R01 HL109031NIDA NIH HHS P50 DA019706
6 · The paper itself

Abstract

unlabelledWeight gain after smoking cessation may increase diabetes mellitus and impaired fasting glucose (IFG) risk. This study evaluated associations between smoking cessation and continued smoking with incident diabetes and IFG three years after a quit attempt. The 1504 smokers (58% female) were mean (standard deviation) 44.7 (11.1) years old and smoked 21.4 (8.9) cigarettes/day. Of 914 participants with year 3 data, the 238 abstainers had greater weight gain, increase in waist circumference, and increase in fasting glucose levels than the 676 continuing smokers (p ≤ 0.008). In univariate analyses, Year 3 abstinence was associated with incident diabetes (OR = 2.60, 95% CI 1.44-4.67, p = .002; 4.3% absolute excess) and IFG (OR = 2.43, 95% CI 1.74-3.41, p<0.0001; 15.6% absolute excess). In multivariate analyses, incident diabetes was associated independently with older age (p = 0.0002), higher baseline body weight (p = 0.021), weight gain (p = 0.023), baseline smoking rate (p = 0.008), baseline IFG (p<0.0001), and baseline hemoglobin A1C (all p<0.0001). Smoking more at baseline predicted incident diabetes among eventual abstainers (p<0.0001); weighing more at baseline predicted incident diabetes among continuing smokers (p = 0.0004). Quitting smoking is associated with increased diabetes and IFG risk. Independent risk factors include older age, baseline body weight, baseline glycemic status, and heavier pre-quit smoking. These findings may help target smokers for interventions to prevent dysglycemia.

trial registrationClinicaltrials.gov NCT00332644.

Indexed as

Smoking CessationAdultBlood GlucoseDiabetes MellitusFastingFemaleHumansLogistic ModelsMaleMiddle AgedMultivariate AnalysisRisk FactorsTime FactorsTreatment OutcomeBlood Glucose

Identifiers

PMID24893290
PMCPMC4043674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.